Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma

von Gao, Jing, Zou, Zhengzhi, Gao, Jing, Zhang, Haifang, Lin, Zhicai, Zhang, Yaya, Luo, Xianyang, Liu, Changhua, Xie, Jingdun, Cai, Chengfu
Veröffentlicht in Int J Clin Exp Pathol (2015)

A Suppressor of Cytokine Signaling 1 Antagonist Enhances Antigen-Presenting Capacity and Tumor Cell Antigen-Specific Cytotoxic T Lymphocyte Responses by Human Monocyte-Derived Dend...

von Wang, Yongjun, Wang, Shengyu, Ding, Yuan, Ye, Yanhua, Xu, Yingyi, He, Huixiang, Li, Qiaozhen, Mi, Yanjun, Guo, Chunhua, Lin, Zhicai, Liu, Tao, Zhang, Yaya, Chen, Yuqiang, Yan, Jianghua
Veröffentlicht 2013

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

von Li, Chenggong, Sun, Yan, Wang, Jing, Tang, Lu, Jiang, Huiwen, Guo, Tao, Liu, Lin, Wu, Yaohui, Ai, Lisha, Xia, Linghui, Wu, Jianjun, Lin, Zhicai, Qian, Qijun, Hu, Yu, Mei, Heng
Veröffentlicht in Front Immunol (2021)

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

von Fang, Juemin, Ding, Na, Guo, Xianling, Sun, Yan, Zhang, Zhiwei, Xie, Bailu, Li, Zhong, Wang, Hui, Mao, Wei, Lin, Zhicai, Qin, Fei, Yuan, Min, Chu, Wenqi, Qin, Huanlong, Qian, Qijun, Xu, Qing
Veröffentlicht in J Immunother Cancer (2021)